/
Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States.
Mentions
3 mentions · latest on 6 Oct 2026
See which tracked investors hold Nautilus Biotechnology, Inc. →Ownership and position changes on OwnershipTrace
| All Roads Lead to Nautilus Biotechnology | - | 6 Oct 2026 | |
| Life Extension per Token | - | 30 Sept 2026 | |
| Nautilus: Tesla for Proteomics. | - | 28 Sept 2026 |